Biosurfit, SA of Azambuja at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair
Manufacturers OEM

Biosurfit, SA

Quinta do Covão, Rua 25 de Abril nº 66, 2050-317 Azambuja
Portugal

Telephone +351 21 8860169
Fax +351 21 8860131
info@biosurfit.com

Hall map

MEDICA 2017 hall map (Hall 18): stand J14

Fairground map

MEDICA 2017 fairground map: Hall 18

Contact

Ana Santos

Visit us

Hall 18 / J14

13.11.2017

Topic

Download

all-day

how to perform a test | demo

14.11.2017

Topic

Download

all-day

how to perform a test | demo

15.11.2017

Topic

Download

all-day

how to perform a test | demo

16.11.2017

Topic

Download

all-day

how to perform a test | demo

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.01  General Diagnostics

General Diagnostics

  • 01  Electromedical equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.01  General Diagnostics
  • 01.01.01.16  Information medical equipment, whole body diagnostic equipment

Information medical equipment, whole body diagnostic equipment

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.10  Devices and systems for haemoglobin determination

Devices and systems for haemoglobin determination

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.10  Devices and systems for haemoglobin determination
  • 03.01.10.02  Fully automatic glycosylated haemoglobin determination

Fully automatic glycosylated haemoglobin determination

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry

Rapid tests - clinical chemistry

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry
  • 03.01.14.01  Point of care - testing systems

Point of care - testing systems

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems

Immuno assay systems

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.14  Specific proteins

Specific proteins

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.14  Specific proteins
  • 03.02.14.01  C-reactive proteins (CRP)

C-reactive proteins (CRP)

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.01  Differential cell counters

Differential cell counters

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.01  Differential cell counters
  • 03.03.01.02  Differential cell counters

Differential cell counters

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.09  Immunohaematology (Blood grouping)

Immunohaematology (Blood grouping)

Our products

Product category: General Diagnostics, Information medical equipment, whole body diagnostic equipment, Devices and systems for haemoglobin determination, Fully automatic glycosylated haemoglobin determination, Rapid tests - clinical chemistry, Point of care - testing systems, Immuno assay systems, Specific proteins, C-reactive proteins (CRP), Differential cell counters, Differential cell counters, Immunohaematology (Blood grouping)

Our products

biosurfit is a point-of-care (PoC) diagnostics company with highly innovative proprietary technology. biosurfit’s spinit® platform is the first, and only, diagnostic system capable of performing the major PoC blood test modalities (haematology, immunoassays and clinical chemistry) on the same instrument. biosurfit’s current pannel consists of: C-Reactive Protein (CRP), Blood Count (BC) and HbA1c (Glycated Haemoglobin), all CE-marked and launched in the EU. An extensive test menu is expected to be rolled-out in the EU and USA over the next 3 years with parameters such as: Diabetes, Cardiac, Metabolic pannels. 

More Less

Product category: C-reactive proteins (CRP)

C-reactive protein

The spinit® CRP disposable disc is used with the spinit® instrument as a quantitative assay for the measurement of c-reactive protein concentration in whole blood (venous and capillary), serum and plasma samples.

About CRP
C-reactive protein is an acute-phase protein produced by hepatocytes in response to a cytosine stimuli being released to bloodstream. After the inflammatory stimuli, CRP concentration in blood increases within 24 to 48 hours with the highest level being reached at the acute phase of the inflammatory response. This type of assay is used for detection and evaluation of infection, tissue injuries, inflammatory responses and associated diseases. The increase of CRP level in blood is not specific in several disease associated processes and should not be interpreted without a complete clinical evaluation.

More Less

Product category: Differential cell counters

BC - Blood Count

The spinit® BC disposable disc is used with the spinit® instrument as a quantitative assay for the measurement of total leucocytes, 5 part differential white blood cells and haematocrit.

About BC
A differential blood count with haematocrit measurement can better direct your decision making process. Specially, it can allow the physicians to give faster and more accurate diagnosis to their patients and therefore reduce the length of stay and flow of people in the primary care and emergency departments.

More Less

Product category: Fully automatic glycosylated haemoglobin determination

spinit® HbA1c

The spinit® HbA1c disposable disc is used with the spinit® instrument as a quantitative assay for the measurement of HbA1c - glycosylated haemoglobin in whole blood (venous and capillary).

About HbA1c
The measurement of HbA1c is used as a diagnostic tool to identify patients who may be at risk for developing diabetes mellitus and is recommended for monitoring long-term blood glucose control in individuals with diabetes mellitus. Additionally, HbA1c concentration levels correlate well with the risk of long-term macro and microvascular diabetes complications. The development of such complications can be retarded by defining specific treatment targets and decision limits to achieve adequate metabolic control. The use of point of care testing for HbA1c measurement enables rapid provision of information regarding patient glycaemic history, which allows for timely decisions on therapeutic regimen, enhancing the likelihood of patient compliance to the treatment.

More Less

About us

Company details

company:mission
At biosurfit we are working to shape the future of in-vitro diagnostic testing. 

We want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients.

company:values
At biosurfit, our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. Our best assets are Innovative, Excellent, Responsible and Fair.
biosurfit guides its activities under an impeccable and socially responsible code of ethical conduct. This can be seen in all our internal and external relationships with employees, shareholders, customers, suppliers, universities and partners, public entities, official entities, press or public. biosurfit´s ethical conduct is practised daily by all of its’ employees while performing their daily activities.

More Less